News
Swiss Deep Tech News & Analysis
Stay informed on the Swiss technology landscape. This is your central resource for Deep Tech News, combining key developments from across the ecosystem with original, data-driven analysis from the Deep Tech Nation Foundation. We track and report on significant technological milestones, funding rounds, and research to provide a comprehensive overview for international investors, partners, and researchers.
Curated Newsfeed
-
Boehringer Ingelheim acquires equine health startup Evax
startupticker.ch
-
London-based market intelligence company acquires Square Commodities
startupticker.ch
-
Vaderis Therapeutics closes USD 152 million Series B Financing
startupticker.ch
-
Terra Quantum partners with Apex.AI on quantum-safe security
startupticker.ch
DTN Highlights
-
Read more: Swiss Scale-Up Report 2026: Built Here, Financed AbroadFor the first time, Switzerland’s scale-ups have been counted company by company. The Swiss Scale-Up Report 2026, published on September 16, 2026 by Deep Tech…
-
Read more: swisscanto: A Matter of ScaleThe Flywheel Switzerland Hasn’t Built Roughly seventy percent of the Swiss Growth Fund’s money is invested in Switzerland, and Nils Granath is clear that this…
-
Read more: swisscanto: Backed to the FutureThree Companies That Almost Stopped Running Nils Granath invests in the growth stage of the Swiss market, and it is the part where the money…
-
Read more: swisscanto: At Face ValueThe Marathon Runner In the mid-1990s, the European mobile telecoms industry was hiring at a pace that was breaking its own buildings. Ericsson, the Swedish…
-
Read more: Swiss Venture Capital Steadies at $1.58 Billion in H1 2026 as Hardware Sets a RecordSwiss venture capital returned to a familiar level in the first half of 2026. Startups raised $1.58 billion (CHF 1.245 billion) across 123 financing rounds,…
-
Read more: Swiss Deep Tech Report 2026: Switzerland Leads the Technologies Reshaping the Global EconomyThe technologies now driving the global economy, advanced computing, artificial intelligence, and robotics, are built patiently, over decades of investment and scientific groundwork. So are…
-
Read more: Swiss Venture Capital Matures: Returns, Exits, and a Sharper Investor LayerSwiss venture capital recorded its first annual rebound since 2022 last year, with CHF 2.95 billion invested and a record CHF 1.116 billion flowing into…
-
Read more: Bridging the tough middle: Key takeaways from the Deep-Tech x Space SummitESA chose ESDI at Park Innovaare for its first dedicated Deep-Tech × Space Summit on 13 May 2026. Deep Tech Nation Switzerland CEO Joanne Sieber…
-
Read more: SICTIC: A Matter of ScaleIn Parts 1 and 2 of our series, we followed Thomas Dübendorfer from a student fund at ETH Zurich to SICTIC, Switzerland’s largest angel investor…
-
Swiss industrial company Bystronic acquires Isochronic
Bystronic has entered into an agreement to acquire Isochronic AG, a Swiss automation technology company founded in 2020 and specializing in high-speed robotic sorting systems…
startupticker.ch
startupticker.ch: Swiss industrial company Bystronic acquires Isochronic- Bystronic acquired Isochronic AG, a Swiss automation company specializing in high-speed robotic sorting systems for sheet metal processing.
- Isochronic uses advanced robotic kinematics and proprietary software for automated material handling and sorting in laser cutting.
- The acquisition combines Isochronic's robotics expertise with Bystronic's global reach and industrial knowledge for expanded automation.
-
Adaptyv raises $40M to build automated lab for agentic biology
Biopôle-based Adaptyv Biosystems just raised a $40M Series A to build the automated lab for agentic biology, The Swiss startup develops a protein engineering platform…
startupticker.ch
startupticker.ch: Adaptyv raises $40M to build automated lab for agentic biology- Adaptyv Biosystems raised $40M Series A for AI-powered lab automation in protein engineering, targeting 3x capacity growth by end of 2026.
- The company grew lab throughput 5x in one year and serves 100+ customers including Roche, Novo Nordisk, and AI biotech startups.
- Adaptyv plans to expand into higher-value biology including developability, peptides, ADCs, and cell-based functions.
-
Lookthrough acquires BuildingMinds from Schindler
The transaction brings together two complementary businesses into one profitable AI software company serving institutional investors, governments and global technology companies, strengthening its position for…
startupticker.ch
startupticker.ch: Lookthrough acquires BuildingMinds from Schindler- Lookthrough and BuildingMinds merged to create an AI platform covering 100,000+ buildings across 64 countries for institutional real estate.
- The combined platform helps institutional investors shift from ESG compliance reporting to data-driven investment location decisions.
- BuildingMinds keeps Berlin operations and brand while Schindler remains the largest shareholder of the new company.
-
Gravis Robotics Raises $200M for Construction Autonomy
Today, Gravis Robotics has officially announed a $200M investment from SoftBank Investment Advisers, the largest ever Series A raised in construction robotics history. With systems…
startupticker.ch
startupticker.ch: Gravis Robotics Raises $200M for Construction Autonomy- Gravis Robotics raised $200M Series A from SoftBank, the largest construction robotics funding round, reaching $1B valuation.
- Gravis' AI software works across mixed equipment fleets, delivering up to 30% productivity gains on construction jobsites.
- The company uses simulated training data to teach machines autonomous excavation with precision in unpredictable soil conditions.
-
Indivi attracts Infosys Innovation Fund as strategic investor
Together with Infosys, Indivi aims to fundamentally unlock early-stage clinical development elevating tech-science at the epicenter of precision drug development in neurology. With its platform…
startupticker.ch
startupticker.ch: Indivi attracts Infosys Innovation Fund as strategic investor- Indivi's smartphone platform enables frequent assessment of motor and cognitive function to detect early treatment effects in neuroscience trials.
- Infosys' investment helps Indivi scale its commercial organization and expand its digital biomarker platform across neuroscience programs.
- Infosys and Indivi combine AI and machine learning with neuroscience expertise to accelerate drug development for Parkinson's and Alzheimer's.
-
Bruker makes minority investment in Atinary
Bruker Corporation entered into an expanded strategic collaboration with Atinary Technologies Inc., the pioneer of Self-Driving Labs technologies and AI-driven R&D with applications in pharmaceuticals,…
startupticker.ch
startupticker.ch: Bruker makes minority investment in Atinary- Bruker invested in Atinary to integrate analytical instruments, lab automation, and AI into Self-Driving Labs platforms.
- Atinary's SDLabs platform automates Design-Make-Test-Analyze-Learn workflows using AI agents for faster discovery.
- Demo labs in Basel and Boston integrate Chemspeed robotics, Bruker NMR, and Atinary's agentic AI technology.
-
Boehringer Ingelheim acquires equine health startup Evax
Boehringer Ingelheim has acquired Evax AG, a Swiss biotech company focused on therapeutic vaccines to address significant unmet needs in horses, particularly for the treatment of allergic…
startupticker.ch
startupticker.ch: Boehringer Ingelheim acquires equine health startup Evax- Boehringer Ingelheim acquired Swiss biotech Evax AG, which develops therapeutic vaccines using virus-like particles for allergic skin diseases in horses.
- Evax's vaccine targets the root cause of equine allergies, offering longer-lasting relief than current shampoo and corticosteroid treatments.
- The acquisition expands Boehringer Ingelheim's therapeutic vaccine portfolio for animal health, following its 2024 Saiba Animal Health acquisition.
-
London-based market intelligence company acquires Square Commodities
FGE NexantECA has completed the acquisition of Morges-based Square Commodities ("SquareCo"), the leading research and data analytics platform specialising in the global renewable fuels market. Founded…
startupticker.ch
startupticker.ch: London-based market intelligence company acquires Square Commodities- FGE NexantECA acquired Square Commodities, a renewable fuels research platform, to enhance oil demand modeling with regulatory expertise.
- Square Commodities will integrate into Lumen, FGE NexantECA's AI platform, to improve renewable fuels market analysis capabilities.
- Founder Olivier Pellegrinelli will lead renewable fuels research, bringing over a decade of biofuels regulation and market experience.
-
Vaderis Therapeutics closes USD 152 million Series B Financing
Basel-based Vaderis Therapeutics, a clinical-stage biopharmaceutical company focused on developing targeted therapies for rare vascular diseases, today announced the closing of a private $152 million…
startupticker.ch
startupticker.ch: Vaderis Therapeutics closes USD 152 million Series B Financing- Vaderis raised $152M in Series B funding to advance engasertib into Phase 3 trials for hereditary hemorrhagic telangiectasia (HHT).
- Engasertib, an oral AKT inhibitor, showed sustained improvements in HHT patients and could be the first approved HHT-specific therapy.
- The HEROIC Phase 3 study is a global, randomized, placebo-controlled trial for moderate-to-severe HHT across three continents.
-
Terra Quantum partners with Apex.AI on quantum-safe security
Swiss startup Terra Quantum and California-based Apex.AI have demonstrated a quantum-safe security solution for long-lived, cloud-connected software-defined systems. The joint solution is designed to help…
startupticker.ch
startupticker.ch: Terra Quantum partners with Apex.AI on quantum-safe security- Terra Quantum and Apex.AI demonstrated a quantum-safe security solution using NIST-standardized post-quantum cryptography.
- The solution maintains compatibility with existing software while preparing organizations for future quantum computing threats.
- Mission-critical aerospace, defense, and infrastructure systems need post-quantum security now as today's devices will outlast current standards.
-
Exclaim Robotics raises USD 4.95 million for data centre repair robots
Exclaim Robotics has emerged from stealth with a USD 4.95 million pre-seed round co-led by Founderful and Playfair. The Zurich-based startup is building autonomous mobile…
startupticker.ch
startupticker.ch: Exclaim Robotics raises USD 4.95 million for data centre repair robots- Exclaim Robotics raised $4.95M to build autonomous robots for hazardous maintenance tasks in AI data centres, addressing 800V DC power system safety risks.
-
Two Swiss biotechs clear US regulatory steps for heart and nerve therapies
HAYA Therapeutics has won Fast Track designation from the US Food and Drug Administration for its lead cardiac fibrosis candidate, while Oculis has received FDA…
startupticker.ch
startupticker.ch: Two Swiss biotechs clear US regulatory steps for heart and nerve therapies- HAYA Therapeutics received FDA Fast Track designation for HTX-001, an antisense oligonucleotide for cardiac fibrosis in hypertrophic cardiomyopathy.
- Oculis can cross-reference existing data to expand Privosegtor into acute multiple sclerosis relapse treatment, per FDA feedback.
- Privosegtor showed positive Phase 2 data in optic neuritis and uses the same 3mg/kg dose across MS relapse types.
-
Read more: ACE Ventures: A Matter of ScaleImpatience is Imperative There is a distinct cultural friction when a Swiss founder steps into the US market. In Switzerland, the prevailing operating system is…
-
Read more: ACE Ventures: Backed to the FutureThe Art of the Imperfect Bet A venture capitalist is only as good as their conviction when things look messy. For Alessandra Agnello, the “perfect deal”…
-
Read more: ACE Ventures: At Face ValueFrom Equations to Exposure It isn’t surprising that Alessandra Agnello, Director at ACE Ventures, describes Venture Capital as picking out gems out of a pile of rocks- after all, her…
-
Read more: Small Country, Big Deep Tech Nation: Switzerland as Europe’s Technology HubWhile the world talks about GenAI, Switzerland is quietly building something almost as significant: an industry founded on physics, precision, and patience. Deep tech—the fusion…
-
Read more: The Evidence We Needed: Establishing the First Benchmark for Swiss VC ReturnFor years, institutional investors have cited the same obstacle when asked about venture capital allocation: insufficient performance data. Without a credible benchmark, Swiss pension funds…
-
Read more: NextIn Business: Switzerland’s AI-Powered Response to the Workplace Mental Health CrisisOne in three sick notes in Switzerland stems from mental health issues, with workplace stress as the primary culprit. As the World Health Organization (WHO)…
-
Read more: Beyond Early Stage: The Rise of the Swiss Scale Up EngineFor years, the global narrative regarding European innovation has been consistent: excellent research, strong early-stage formation, but a fragmentation that hampers growth. However, new data…
-

NextIn Business: Swiss Drones – Flying Robots Transform Industrial Inspection and Emergency Response
Read more: NextIn Business: Swiss Drones – Flying Robots Transform Industrial Inspection and Emergency ResponseWhere humans cannot safely reach, such as in burning buildings, on collapsed structures, or atop windswept industrial towers, Swiss drones are redefining what is possible.…
-
Read more: So Far, We Feed the Roots, but Others Reap the HarvestSwitzerland reigns as the world’s innovation champion. Yet Joanne Sieber, CEO of the Deep Tech Nation Switzerland Foundation, warns against complacency. In this interview, she…
-
Read more: Project Switzerland: 20 outstanding entrepreneurs for next-gen market leadersSwitzerland is consistently hailed as the world champion of innovation. Yet, the critical challenge remains: scaling these innovations into enduring, global companies. Many promising Swiss…
-
Read more: Spacetek Technology Secures CHF 9.6M to Bring Swiss Space Tech to Global SemiconductorsIn the global race for semiconductor dominance, yield and efficiency are the ultimate currency. As manufacturers push for nanometer precision, the margin for error effectively…
-
Read more: NextIn Business: Swiss Biotech Battles Superbugs – Deep Tech Solutions to Antibiotic ResistanceModern medicine faces an existential threat: multi-resistant bacteria. As vital antibiotics “no longer work”, infections once easily treated are becoming life-threatening, and routine procedures like…